... dental and medical practitioners, should be aware of the presenting features of headandneck cancer, and the local referral pathways for suspected cancers. 2.5 SCREENING FOR HEADANDNECKCANCER ... up. 2 PRESENTATION, SCREENING AND RISK FACTORS24DIAGNOSIS AND MANAGEMENT OF HEADANDNECK CANCER 1++2++1++1++1++For patients with advanced headandneck cancer, where postoperative ... TUMOUR AND NECK Scottish Intercollegiate Guidelines NetworkDiagnosis and management of head andneck cancer A national clinical guidelineOctober 200636DIAGNOSIS AND MANAGEMENT OF HEADAND NECK...
... guide to neck dissection classification and TNMstaging of headandneckcancer / Committee for Neck DissectionClassification, American HeadandNeck Society [and] Committee for Head andNeck Surgery ... Guide to NECK DISSECTIONCLASSIFICATION AND TNMSTAGING OF HEAD AND NECK CANCER Committee for HeadandNeck Surgery and OncologyAmerican Academy of Otolaryngology– Head andNeck Surgery Neck Dissection ... guide to neck dissection classification and TNM staging of head and neck cancer. — 3rd ed. / Committee for HeadandNeck Surgery and Oncol-ogy, American Academy of Otolaryngology HeadandNeck Surgery...
... consideration.ALL HEADANDNECK CANCERSEarly oropharyngeal cancer Patients with early oropharyngeal cancer may be treated by: primary resection, with reconstruction as appropriate, andneck dissection ... AND SCREENINGREFERRALDIAGNOSIS AND STAGINGPatients should be seen within two weeks of urgent referral. All patients withheadandneckcancer should have direct pharyngolaryngoscopy and ... surface of the lip.Oral cavityLarynxOropharynxHypopharynxALL HEADANDNECK CANCERSDiagnosis and management of headandneck cancer Quick Reference Guide October 200690COPIES OF ALL SIGN...
... c-erbB2 and other markers in patientstreated with chemotherapy for recurrent headandneck cancer. Head Neck 2000, 22:599-608.33. Werkmeister R, Brandt B, Joos U: Clinical relevance of erbB-1 and ... strongly associatedwith poor prognosisof pat ients with HNSCC and is a potential candidate molecule for targeted therapy.BackgroundThe majority of tumors that arise in the headand neck region ... squamous head and neck carcinomas. HeadNeck 2007, 29:655-664.12. Wei Q, Sheng L, Shui Y, Hu Q, Nordgren H, Carlsson J: EGFR, HER2, and HER3 expression in laryngeal primary tumors and correspondingmetastases....
... c-erbB2 and other markers in patientstreated with chemotherapy for recurrent headandneck cancer. Head Neck 2000, 22:599-608.33. Werkmeister R, Brandt B, Joos U: Clinical relevance of erbB-1 and ... strongly associatedwith poor prognosisof pat ients with HNSCC and is a potential candidate molecule for targeted therapy.BackgroundThe majority of tumors that arise in the headand neck region ... squamous head and neck carcinomas. HeadNeck 2007, 29:655-664.12. Wei Q, Sheng L, Shui Y, Hu Q, Nordgren H, Carlsson J: EGFR, HER2, and HER3 expression in laryngeal primary tumors and correspondingmetastases....
... thyroid cancer, which presents in asimilar way and must be differentiated from lymphoma with abiopsy.Other cancers of the headand neck There are a wide range of other cancers of the headandneck ... also includes cancers and sarcomas of the facial bones,peripheral nerves, connective and soft tissues, and various glands. Skull base cancers are included among headandneck cancers, buttumours ... oropharynx in Turin, Italy. Scand J Work Environ Health 1991;17:248-254.Services for patients withheadand neck cancer One of the striking characteristics of headandneckcancer services isthe range...